SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (40342)12/7/1999 8:04:00 PM
From: myturn  Read Replies (1) | Respond to of 108040
 
I shorted it this morning. Press release is nothing but fluff. Look who paid for the GERN research to be done and look who issued the PR on behalf of GERN.



To: Anthony@Pacific who wrote (40342)12/7/1999 10:06:00 PM
From: Jane4IceCream  Read Replies (1) | Respond to of 108040
 
Anthony,

You still long Imclone??

I am. Tucked away in my long portfolio. Added more on the large dip to the lower 20's recently.

Hope all is well. Say hello to Mary!!

Jane



To: Anthony@Pacific who wrote (40342)12/8/1999 8:24:00 AM
From: Rock_nj  Read Replies (1) | Respond to of 108040
 
Congrats on your GERN short. It was a good short-term call. But I must tell you, I think Geron/GERN is onto something. It is true that the lifetime of a cell is regulated by the length of telomerase. This is not medical quackery. If a the length of a cell's telomerase can be controlled then the life of the cell can be controlled. Cancer cells can be altered to self destruct by shortening their telomerase.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News